These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37983883)

  • 1. Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study).
    Måseide RJ; Berntorp E; Astermark J; Olsson A; Bruzelius M; Frisk T; Nummi V; Lassila R; Tjønnfjord GE; Holme PA
    Haemophilia; 2024 Jan; 30(1):98-105. PubMed ID: 37983883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study.
    Måseide RJ; Berntorp E; Astermark J; Olsson A; Bruzelius M; Frisk T; Nummi V; Lassila R; Tjønnfjord GE; Holme PA
    Haemophilia; 2020 Sep; 26(5):891-897. PubMed ID: 33021747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation.
    Måseide RJ; Berntorp E; Nummi V; Lassila R; Tjønnfjord GE; Holme PA
    Haemophilia; 2021 Sep; 27(5):793-801. PubMed ID: 34106506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study.
    Måseide RJ; Berntorp E; Astermark J; Hansen J; Olsson A; Bruzelius M; Frisk T; Aspdahl M; Nummi V; Tjønnfjord GE; Holme PA
    Haemophilia; 2021 Mar; 27(2):e253-e259. PubMed ID: 33550602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference in quality of life between persons with severe haemophilia A and B.
    Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Gretenkort Andersson N; Berntorp E; Astermark J
    Haemophilia; 2023 Jul; 29(4):987-996. PubMed ID: 36791275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and health status in adolescent and adult people with haemophilia A without factor VIII inhibitors-A non-interventional study.
    Oldenburg J; Tran H; Peyvandi F; Núñez R; Trask P; Chebon S; Mahlangu JN; Lehle M; Jiménez-Yuste V; von Mackensen S
    Haemophilia; 2021 May; 27(3):398-407. PubMed ID: 33576546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A.
    Arvanitakis A; Holme PA; Berntorp E; Astermark J
    Haemophilia; 2023 Jul; 29(4):1032-1038. PubMed ID: 37252898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register.
    Osooli M; Steen Carlsson K; Baghaei F; Holmström M; Rauchensteiner S; Holme PA; Hvitfeldt L; Astermark J; Berntorp E
    Haemophilia; 2017 May; 23(3):e180-e187. PubMed ID: 28393468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in health-related quality of life in patients with haemophilia B treated with nonacog beta pegol, a new extended half-life recombinant FIX product.
    Chowdary P; Kearney S; Regnault A; Hoxer CS; Yee DL
    Haemophilia; 2016 Jul; 22(4):e267-74. PubMed ID: 27352908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials.
    Oladapo AO; Epstein JD; Williams E; Ito D; Gringeri A; Valentino LA
    Haemophilia; 2015 Sep; 21(5):e344-58. PubMed ID: 26390060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.
    Scott MJ; Xiang H; Hart DP; Palmer B; Collins PW; Stephensen D; Sima CS; Hay CRM
    Haemophilia; 2019 Mar; 25(2):205-212. PubMed ID: 30408835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
    Gringeri A; Leissinger C; Cortesi PA; Jo H; Fusco F; Riva S; Antmen B; Berntorp E; Biasoli C; Carpenter S; Kavakli K; Morfini M; Négrier C; Rocino A; Schramm W; Windyga J; Zülfikar B; Mantovani LG
    Haemophilia; 2013 Sep; 19(5):736-43. PubMed ID: 23731246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.
    Soucie JM; Grosse SD; Siddiqi AE; Byams V; Thierry J; Zack MM; Shapiro A; Duncan N;
    Haemophilia; 2017 Jul; 23(4):e287-e293. PubMed ID: 28574229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study.
    Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Osooli M; Berntorp E; Astermark J
    Haemophilia; 2021 May; 27(3):366-374. PubMed ID: 33780113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of severe haemophilia A on patients' health status: results from the guardian(™) 1 clinical trial of turoctocog alfa (NovoEight(®) ).
    Ozelo M; Chowdary P; Regnault A; Busk AK
    Haemophilia; 2015 Jul; 21(4):451-7. PubMed ID: 25677761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.
    Kennedy M; O' Mahony B; Roche S; McGowan M; Singleton E; Ryan K; O' Connell NM; Pipe SW; Lavin M; O' Donnell JS; Turecek PL; Gormley J;
    Eur J Haematol; 2022 Jun; 108(6):518-527. PubMed ID: 35258118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.
    Hoots WK; Ebbesen LS; Konkle BA; Auerswald GK; Roberts HR; Weatherall J; Ferran JM; Ljung RC;
    Haemophilia; 2008 May; 14(3):466-75. PubMed ID: 18282155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life of moderate and severe haemophilia patients: Results of the haemophilia-specific quality of life index in Korea.
    Baek HJ; Park YS; Yoo KY; Cha JH; Kim YJ; Lee KS
    PLoS One; 2020; 15(9):e0238686. PubMed ID: 32881977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study.
    Tagliaferri A; Feola G; Molinari AC; Santoro C; Rivolta GF; Cultrera DB; Gagliano F; Zanon E; Mancuso ME; Valdré L; Mameli L; Amoresano S; Mathew P; Coppola A;
    Thromb Haemost; 2015 Jul; 114(1):35-45. PubMed ID: 25855376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint status, pain and quality of life in elderly people with haemophilia: A case-control study.
    Chantrain VA; Foubert A; Meeus M; Lambert C; Lobet S; Maes P; Fransen E; Durnez L; Hermans C; Roussel NA
    Haemophilia; 2023 Nov; 29(6):1621-1632. PubMed ID: 37861076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.